COMMON QUESTIONS
A clear answer beats a clever disclaimer.
Understand the compound, check the exact lot, and read the limits of the available evidence.
01What is Cybertide?+
Cybertide is a public compound research and batch-documentation library. It is not a clinic, pharmacy, laboratory, or medical provider.
02Are all items in the library peptides?+
No. NAD+ is a coenzyme, L-carnitine is an amino-acid derivative, glutathione is a tripeptide antioxidant, and Lipo-C is a variable compounded blend name. The library labels each category clearly.
03Does FDA approval of a molecule mean every version is approved?+
No. Approval attaches to a specific drug product, formulation, manufacturing process, indication, population, and label. A research-market or compounded product is not automatically equivalent.
04How are dose and preparation details handled?+
When an FDA-approved product has official labeling, the profile may summarize that product-specific context and link to the label. Experimental compounds do not receive a generalized human-use protocol.
05Can I verify a lot number?+
Yes. Enter the exact identifier printed on the vial in Batch lookup. When a matching report is on file, the site shows its laboratory, date, tests, results, and original source document.
06What does ‘report on file’ mean?+
It means Cybertide has published a submitted laboratory document for that exact lot. It does not independently prove chain of custody or extend the result to a different lot.
07Is this medical advice?+
No. It is educational information and brand documentation. Medical decisions belong with a qualified clinician who knows the patient, indication, formulation, and relevant risks.